Lab business > Market analysis

How to make open innovation work for your company

06 May, 2019

According to Afnan Zafar, collaboration in the field of product development must follow a strict set of rules if firms really want to benefit from open innovation and boost their performance.


Smaller teams produce more innovative research, study finds

14 February, 2019

A new analysis of more than 65 million papers, patents and software projects found that smaller teams produce much more disruptive and innovative research than larger teams.


Australian R&D investment drooping

19 October, 2018

The Australian Government's Science, Research and Innovation (SRI) Budget Tables show that overall investment in research and development is continuing to fall.


UK–US trade deal could threaten the NHS, researchers say

13 July, 2018

The USA's targeting of so-called 'foreign free-riding' in trade deals could lead to a poor deal on pharmaceuticals for the UK post-Brexit.


Gene therapies may not be commercially viable: GlobalData

27 June, 2018

Gene therapies stand to benefit patients immensely, but there are questions about their commercial viability for pharmaceutical companies.


Report: Synthetic biology could be misused to create weapons

21 June, 2018

Although some malicious applications of synthetic biology may not seem plausible right now, they could become achievable with future advances.


Women in STEM: pay improving but opportunities lacking

08 March, 2018

A national survey has revealed that female scientists are not getting the same opportunities for promotion or seniority as their male peers with similar qualifications and experience.


Performance declining for Australia's maths and science students

01 March, 2018

Australia's future is at risk as performance declines amongst our maths and science students, says Science & Technology Australia (STA).


Insights into Australia's clinical trial activity

15 January, 2018

A new report has revealed favourable insights into clinical trials in Australia, where more than $1 billion is invested each year by both government and industry.


In vitro diagnostics market to reach US$69 billion in 2024: GlobalData

13 December, 2017

The overall market value of in vitro diagnostics stands at US$52 billion this year and is projected to grow at a compound annual growth rate of 4.2% to US$69 billion in 2024, according to GlobalData.


More than half of post-surgery antibiotic prescriptions are inappropriate

04 December, 2017

More than half (60%) of antibiotics given to patients after surgery to prevent infections are prescribed inappropriately, usually because they are not required at all — a situation that may be contributing to the rise of antibiotic resistance.


Clarivate Analytics selected as ERA citation provider

24 August, 2017

The Australian Research Council has announced its selection of Clarivate Analytics to provide citation information for the 2018 round of Excellence in Research for Australia (ERA), Australia's national research evaluation framework.


ISA releases Issues Paper for Australian innovation

27 March, 2017

Innovation and Science Australia has released the 2030 Strategic Plan Issues Paper as part of its plan to drive the national conversation around the future of Australian innovation, science and research.


National Science Statement released

24 March, 2017

Arthur Sinodinos has unveiled the National Science Statement, articulating the government's vision and objectives for Australian science.


6 key challenges for Australian innovation

16 March, 2017

Innovation and Science Australia (ISA) Chair Bill Ferris has identified the six key innovation challenges Australia must address in order to become a top-tier innovation nation.


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd